From the TCGA data, we found EZH2 and JARID2 were both significantly upregulated in the HCC group (p-value <0.0001, Figure 1A) and well correlated with similar expression levels (R = 0.74, Figure S1B). This evidence concerns the gene EZH2 and hepatocellular carcinoma.